Financials Luxbright AB

Equities

LXB

SE0015192075

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 05:51:32 2024-05-21 am EDT 5-day change 1st Jan Change
0.988 SEK 0.00% Intraday chart for Luxbright AB +2.49% +137.50%

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019
Net sales 1 1.224 1.4 2.178
EBITDA 1 -7.177 -12.06 -10.52
EBIT 1 -7.194 -12.08 -10.55
Operating Margin -587.89% -862.71% -484.36%
Earnings before Tax (EBT) 1 -6.938 -12.26 -10.65
Net income 1 -6.938 -12.26 -10.65
Net margin -566.98% -875.41% -489.19%
EPS - - -
Free Cash Flow - - -
FCF margin - - -
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 3/26/18 2/29/20 2/29/20
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019
Net Debt 1 4.06 - -
Net Cash position 1 - 5.64 4.27
Leverage (Debt/EBITDA) -0.5659 x - -
Free Cash Flow - - -
ROE (net income / shareholders' equity) 210% -2,568% -122%
ROA (Net income/ Total Assets) -40% -61.4% -43.2%
Assets 1 17.36 19.98 24.65
Book Value Per Share - - -
Cash Flow per Share - - -
Capex - - -
Capex / Sales - - -
Announcement Date 3/26/18 2/29/20 2/29/20
1SEK in Million
Estimates
  1. Stock Market
  2. Equities
  3. LXB Stock
  4. Financials Luxbright AB
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW